The Biologics News and Reports Portal

Show Cart

All Products

Results 141 - 160 of 194

Oct 2013 The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

1,450.00 €

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

2,150.00 €

Jun 2013 Competitor Analysis: Anthrax Vaccines & Therapeutics

200.00 €

May 2013 Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

250.00 €

May 2013 Competitor Analysis: Thrombolytics & Fibrinolytics

250.00 €

May 2013 Competitor Analysis: Coagulation Factors

600.00 €

May 2013 Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors

1,600.00 €

Apr 2013 Competitor Analysis: Insulin

450.00 €

Apr 2013 Competitor Analysis: Interferon

450.00 €

Apr 2013 Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

150.00 €

Apr 2013 Competitor Analysis: Human Growth Hormone (hGH)

300.00 €

Shopping cart

Cart empty

Latest report

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Featured Products

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Shopping cart

Cart empty

Latest report

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Featured Products

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

All Products

Oct 2013 The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

Sep 2013 Competitor Analysis: Pim Kinase Inhibitors

Sep 2013 Competitor Analysis: Wnt Pathway Inhibitors

Aug 2013 Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors

Aug 2013 Competitor Analysis: Focal Adhesion Kinase (FAK) Inhibitors

Aug 2013 Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

Aug 2013 Competitor Analysis: Smallpox Vaccines & Therapeutics

Aug 2013 Competitor Analysis: Poly-Adenyl-Ribose Polymerase (PARP) Inhibitors

Jul 2013 Competitor Analysis ErbB / Her Receptor Antagonists

Jul 2013 Competitor Analysis: c-MET/HGF Inhibitors

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

Jun 2013 Competitor Analysis: Anthrax Vaccines & Therapeutics

May 2013 Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

May 2013 Competitor Analysis: Thrombolytics & Fibrinolytics

May 2013 Competitor Analysis: Coagulation Factors

May 2013 Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors

Apr 2013 Competitor Analysis: Insulin

Apr 2013 Competitor Analysis: Interferon

Apr 2013 Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

Apr 2013 Competitor Analysis: Human Growth Hormone (hGH)

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing